Your browser doesn't support javascript.
loading
P53 is a risk factor of de-novo hepatitis C-related hepatocellular carcinoma treated with direct-acting antivirals: a case-control study.
Omran, Mohamed; Fouda, Manar; Abdelwahab, Abdelwahab Osama; Nabeel, Mohamed Mahmoud; Abdelaziz, Ashraf Omar; Omran, Dalia; Shousha, Hend Ibrahim.
Afiliação
  • Omran M; Chemistry Department, Faculty of Science, Helwan University.
  • Fouda M; Chemistry Department, Faculty of Science, Helwan University.
  • Abdelwahab AO; Chemistry Department, Faculty of Science, Helwan University.
  • Nabeel MM; Endemic Medicine Department, Faculty of Medicine, Cairo University, Cairo, Egypt.
  • Abdelaziz AO; Endemic Medicine Department, Faculty of Medicine, Cairo University, Cairo, Egypt.
  • Omran D; Endemic Medicine Department, Faculty of Medicine, Cairo University, Cairo, Egypt.
  • Shousha HI; Endemic Medicine Department, Faculty of Medicine, Cairo University, Cairo, Egypt.
Eur J Gastroenterol Hepatol ; 34(2): 220-226, 2022 02 01.
Article em En | MEDLINE | ID: mdl-33079785
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Hepatite C Crônica / Neoplasias Hepáticas Tipo de estudo: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Hepatite C Crônica / Neoplasias Hepáticas Tipo de estudo: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article